Injective (INJ) is currently trading at $3.36, reflecting a 2.68% increase over the past 24 hours. The price is near the daily high of $3.36, indicating strong upward momentum, while the daily low was $3.21, suggesting a relatively narrow trading range of just $0.15.

Trading volume over the past 24 hours is 48,542,167, representing a volume-to-market cap ratio of 14.48%. This substantial volume indicates increased investor interest and participation, reinforcing the current bullish trend in the market.

Short-term moving averages reveal a positive trend, with the 8 SMA at $3.34 showing a 0.58% increase and the 13 SMA at $3.32 indicating a 1.24% gain. The 21 SMA and 55 SMA both demonstrate upward movements of approximately 2.12% and 2.11%, respectively, suggesting consistent buying pressure across different time frames.

The 1-hour Relative Strength Index (RSI) is at 74, indicating that INJ may be overbought in the short term. In contrast, the 7-day RSI at 51 suggests a more neutral stance, implying that the asset is not overextended over a longer period, which could provide room for further upside.

Over the past week, INJ has appreciated by 9.66%, while the 14-day and 30-day changes are 12.08% and 9.81%, respectively. This consistent upward movement indicates a solid bullish trend in the medium term, although caution is warranted given the short-term RSI levels.

Injective's all-time high of $52.62, achieved in March 2024, indicates substantial long-term potential. However, current price levels are significantly lower, suggesting a long path for recovery to those peaks, while also highlighting the volatility inherent in the cryptocurrency market.

Given the current data, including strong volume, favorable short-term moving averages, and a bullish medium-term trend, the recommendation for INJ is a Buy. The short-term overbought condition may lead to a slight pullback, but the overall bullish sentiment and upward price trajectory make it an attractive investment opportunity.